Crystal Structure of This DT
Crystallisation Method: EM
Corresponding Chain: A
Sequence Length: 1-1480
Detail: Struture Info
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0060 Transporter Info | ||||
Gene Name | ABCC7 | ||||
Protein Name | Cystic fibrosis transmembrane conductance regulator | ||||
Gene ID | |||||
UniProt ID | |||||
3D Structure |
Crystal Structure of This DT Crystallisation Method: EM Corresponding Chain: A Sequence Length: 1-1480 Detail: Struture Info |
||||
Inter-species Structural Differences (ISD) | |||||
Pongo abelii (Sumatran orangutan) | |||||
Gene Name | CFTR | ||||
UniProt ID | |||||
UniProt Entry | |||||
3D Structure |
Method: Homology modeling Teplate PDB: 5UAK_A Sequence Length: 1480 Identity: 98.919% |
||||
Click to Save PDB File in TXT Format | |||||
Performance | Minimized Score | -3149.304 kcal/mol | |||
Ramachandra Favored |
Medium |
||||
QMEANBrane Quality |
Medium |
||||
Ramachandran Plot |
Ramz Z Score: -1.02 ± 0.21 Residues in Favored Region: 1436 Ramachandran favored: 97.16% Number of Outliers: 8 Ramachandran outliers: 0.54% |
||||
Click to Save Ramachandran Plot in PNG Format | |||||
Local Quality |
QMEANBrane Score: 0.75 |
||||
Click to Save Local Quality Plot in PNG Format | |||||
Xenopus laevis (African clawed frog) | |||||
Gene Name | cftr | ||||
UniProt ID | |||||
UniProt Entry | |||||
3D Structure |
Method: Homology modeling Teplate PDB: 5UAK_A Sequence Length: 1485 Identity: 76.841% |
||||
Click to Save PDB File in TXT Format | |||||
Performance | Minimized Score | -3246.612 kcal/mol | |||
Ramachandra Favored |
Medium |
||||
QMEANBrane Quality |
Medium |
||||
Ramachandran Plot |
Ramz Z Score: -1.09 ± 0.2 Residues in Favored Region: 1432 Ramachandran favored: 96.56% Number of Outliers: 9 Ramachandran outliers: 0.61% |
||||
Click to Save Ramachandran Plot in PNG Format | |||||
Local Quality |
QMEANBrane Score: 0.75 |
||||
Click to Save Local Quality Plot in PNG Format | |||||
References | |||||
1 | Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 2004 Jan 28;23(2):282-93. | ||||
2 | Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol. 2005 Jan;12(1):10-6. | ||||
3 | Requirements for efficient correction of F508 CFTR revealed by analyses of evolved sequences. Cell. 2012 Jan 20;148(1-2):164-74. | ||||
4 | Conformational Changes of CFTR upon Phosphorylation and ATP Binding. Cell. 2017 Jul 27;170(3):483-491.e8. | ||||
5 | Cystic fibrosis transmembrane conductance regulator: solution structures of peptides based on the Phe508 region, the most common site of disease-causing DeltaF508 mutation. Biochemistry. 1999 Jun 8;38(23):7453-61. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.